Pharmaids Pharmaceuticals
47.80
+0.76(+1.62%)
Market Cap₹168.20 Cr
PE Ratio-10.72
IndustryHealthcare
Company Performance:
1D+1.62%
1M-8.48%
6M-26.47%
1Y-33.59%
5Y+336.53%
View Company Insightsright
More news about Pharmaids Pharmaceuticals
25Jul 25
Shankarappa Nagaraja Vinaya Babu Launches Open Offer for 26% Stake in Pharmaids Pharmaceuticals at ₹62.15 Per Share
Shankarappa Nagaraja Vinaya Babu and Tumkur Trade Center Private Limited have announced an open offer to acquire up to 26% stake in Pharmaids Pharmaceuticals at ₹62.15 per share, valuing the deal at ₹56.99 crore. The offer period is from August 4 to August 18, 2025. The acquirers currently hold a combined 24.36% stake, which could increase to 51.28% post-offer. Most existing promoters will seek reclassification as public shareholders, while the acquirers will become new promoters. Pharmaids Pharmaceuticals, engaged in pharmaceutical and biotechnology services, reported a revenue of ₹1,944.74 lakh and a net loss of ₹1,350.51 lakh for FY ending March 31, 2025.
Pharmaids Pharmaceuticals
47.80
+0.76
(+1.62%)
1 Year Returns:-33.59%
Industry Peers
Sun Pharmaceutical
1,691.40
(+0.33%)
Divis Laboratories
6,656.50
(-3.30%)
Cipla
1,505.70
(+0.28%)
Torrent Pharmaceuticals
3,580.00
(+0.75%)
Dr Reddys Laboratories
1,205.40
(+0.02%)
Zydus Life Science
944.10
(+0.79%)
Mankind Pharma
2,261.80
(-2.05%)
Lupin
1,971.80
(+0.83%)
Alkem Laboratories
5,668.50
(+0.44%)
Aurobindo Pharma
1,123.80
(-1.47%)